baber/WOPTO huggingface dataset:
Patent JP-4322961-B2 (JP)
IPC: B01J19/18
Filed: 1997-07-11
Granted: 2009-09-02
Abstract: PCT No. PCT/FR97/01276 Sec. 371 Date Apr. 5, 1999 Sec. 102(e) Date Apr. 5, 1999 PCT Filed Jul. 11, 1997 PCT Pub. No. WO98/02384 PCT Pub. Date Jan. 22, 1998A method is provided for zeolite synthesis from a synthesis medium containing in particular a trivalent aluminum source, a tetravalent silicon source, at least an alkaline or alkaline-earth cation in hydroxide form and water in a reactor containing a solid helical moving body in a guiding tube defining an internal space and a space external to the tube. The invention is characterized in that the synthesis medium is circulated in the reactor in a continuous flow passing through the internal space then the space external to the tube and returning to the internal space, only driven by the roation of the solid helical moving body, at a speed of less than 500 rpm, in the tube which is kept fixed, the synthesis medium being kept at a temperature suitable for at least one of the ripening operations or the crystal growth of the synthesized zeolite. The invention also is directed to a device for implementing the method.
Patent JP-3234946-B2 (JP)
IPC: A61K9/46
Filed: 1991-04-02
Granted: 2001-12-04
Abstract: A pharmaceutical formulation comprising an amoxycillin hydrate and an effervescent couple, for example citric acid plus sodium bicarbonate or sodium glycine carbonate, or tartaric acid or malic plus sodium carbonate. Potassium equivalents of these sodium salts may be used. The formulations may be free flowing powders or granules, or tablets.
Patent JP-H0622034-B2 (JP)
IPC: G06F15/78
Filed: 1988-08-16
Abstract: A vector register provides the capability for simultaneously writing through at least two write ports and simultaneously reading from at least two read ports. In addition, a barber pole technique for storing words from logical vector registers into banks is provided to minimize conflicts.
Patent JP-3202234-B2 (JP)
IPC: C07H19/19
Filed: 1992-11-23
Granted: 2001-08-27
Abstract: This invention relates to a process for the production of 2-fluoropurine derivatives from 2-aminopurine derivatives, which are reacted in HF/pyridine or HF/pyridine/H2O in the presence of a nitrite.
Patent JP-2616252-B2 (JP)
IPC: A61K47/44
Filed: 1993-10-14
Granted: 1997-06-04
Abstract: A method capable of manufacturing wax matrices efficiently in large quantities at once characterized in that a multiscrew extruder is used to achieve the object.
Patent JP-3204320-B2 (JP)
IPC: A61P11/02
Filed: 1991-06-03
Granted: 2001-09-04
Abstract: The invention concerns pharmaceutical preparations for stimulation of the immune system which comprise a cystine derivative as active ingredient.
Patent JP-3174335-B2 (JP)
IPC: F23G7/04
Filed: 1992-12-16
Granted: 2001-06-11
Abstract: PCT No. PCT/GB92/02330 Sec. 371 Date Sep. 12, 1994 Sec. 102(e) Date Sep. 12, 1994 PCT Filed Dec. 16, 1992 PCT Pub. No. WO93/13362 PCT Pub. Date Jul. 8, 1993.Liquid waste material, particularly material containing sulfuric acid, may be combusted using an oxygen-rich material by a process in which: (i) a primary oxidant and fuel issuing from a burner are combusted in a furnace, the proportion of primary oxidant to fuel being such that there is insufficient oxygen to combust the fuel completely; (ii) introducing into the furnace the liquid waste material in atomized form around the burner; (iii) introducing into the furnace spaced from the burner a secondary oxidant which contains sufficient oxygen to combust completely the fuel not combusted by the primary oxidant the direction in which each of the primary oxidant, fuel and liquid waste material is introduced being such that the substances flow in substantially the same direction, the rate at which the primary oxidant, fuel, liquid waste material and secondary oxidant are introduced being such that a plug flow of substances through the furnace is created.
Patent JP-3280024-B2 (JP)
IPC: D06L4/13
Filed: 1992-11-24
Granted: 2002-04-30
Abstract: Removal of naturally occurring triglycerides or ester coatings from natural fibers comprises the sequential steps of: 1) impregnating the fabric with an aqueous solution of lipase to a liquor pick-up ratio of 50-200 %; 2) incubating the impregnated fabric at 15-70  DEG C for 1-24 hours; and 3) washing and rinsing to remove fatty acids.
Patent JP-2921981-B2 (JP)
IPC: C04B41/45
Filed: 1990-09-11
Granted: 1999-07-19
Abstract: PCT No. PCT/GB90/01404 Sec. 371 Date May 11, 1992 Sec. 102(e) Date May 11, 1992 PCT Filed Sep. 11, 1990 PCT Pub. No. WO91/04305 PCT Pub. Date Apr. 4, 1991.An aqueous water repellent composition comprising the reaction product of one or more of a carboxylic acid or anhydride containing from 3 to 22 carbon atoms and a polyfunctional aromatic or aliphatic amine or substituted amine containing from 2 to 25 carbon atoms and a water soluble metal complex crosslinking agent containing one or more metals selected from Groups Ia, IIa, IIla, IVa and the first and second rows of transition metals from the Periodic Table of Elements. The composition may contain wax and is dispersed in water to form a water repellent system.
Patent JP-3736575-B2 (JP)
IPC: A61M25/01
Filed: 1995-12-11
Granted: 2006-01-18
Abstract: The catheter insertion device of the present invention includes a catheter dispenser having a catheter outlet extending from a base and a drum receptacle engaged to the base in a rotating relationship. An inlet opening in the base is coaxially aligned with the catheter outlet. A passageway extends from the inlet opening tangentially through the catheter drum to the catheter outlet. A rigid needle is disposed through the passageway so that the sharp tip extends beyond the catheter outlet. A flexible introducer catheter generally contiguously and telescopically surrounds the distal portion of the needle. The introducer catheter extends beyond the catheter outlet to a position on the needle that is proximate to the sharp tip and is operatively associated with the needle for insertion into the vein of a patient. A one way flow valve is in fluid-tight connection with the proximal end of the flexible introducer catheter. The valve forms a portion of the passageway so that when the needle is slidably removed from the passageway the valve minimizes the fluid backflow from the vein. When the catheter drum is rotated relative to the base, the drum catheter is threadably inserted into and through the one way valve, through the indwelling flexible introducer catheter and into the vein of the patient.
Patent JP-4008038-B2 (JP)
IPC: A61B17/70
Filed: 1997-11-05
Granted: 2007-11-14
Abstract: In one embodiment, a spinal fixation assembly includes an elongated member, such as a spinal rod, configured for placement adjacent the spine and a bone engaging fastener, such as a bone screw having a lower portion configured for engaging a vertebra and a head that is at least partially spherical. The assembly further includes a receiver member defining a bore therethrough from a top end to a bottom end, a recess for receiving the head of the bone screwing fastener therein, and a lower opening at said bottom end of the receiver member through which the bone screw extends. The recess is configured to at permit pivoting of the bone screw within the receiver member until the head is fixed within the recess. The receiver member also includes a channel communicating with the bore and having an upper opening at the top end of the receiver member for insertion of the spinal rod into the channel. In one embodiment, two compression members are provided, each being formed of a temperature responsive material and having a first configuration at a first temperature and a different second configuration at a different second temperature in which the compression member contracts about a portion of the receiver member to thereby compress the receiver member about both the head of the bone screw within the recess and the spinal rod within the channel.
Patent JP-3861165-B2 (JP)
IPC: B60L13/03
Filed: 1997-02-08
Granted: 2006-12-20
Abstract: The method provides an electromagnetic assembly in the form of a magnet pole or of a stator packet of an extended stator linear motor for a magnetic levitation train. The assembly includes a sheet stack (8) made of ferromagnetic material and at least one additional component (12,13,14). The sheet stack (8) is assembled from raw magnetic steel sheets and is positioned in a shaping tool. Thereafter by feeding a hardenable mixture into the tool and hardening or hardening out the mixture, the sheets are surrounded with the mixture and connected to each other in a single working step to form the finished sheet stack. In the same working step, the sheet stack (8) is connected to the additional component (12,13,14) and the assembly as a whole is provided with its final electrical, magnetic, mechanical and/or geometric properties.
Patent JP-3447011-B2 (JP)
IPC: C07D213/82
Filed: 1997-06-25
Granted: 2003-09-16
Abstract: PCT No. PCT/KR97/00123 Sec. 371 Date Dec. 21, 1998 Sec. 102(e) Date Dec. 21, 1998 PCT Filed Jun. 25, 1997 PCT Pub. No. WO98/00394 PCT Pub. Date Jan. 8, 1998The present invention relates to a novel benzoyl urea derivative which exhibits potent growth-retarding activity against pests and which is represented by formula (I), in which A represents N or CH, and X1 and X2 independently of one another represent hydrogen, fluoro, chloro or bromo.
Patent EA-006198-B2 (EA)
Title: Process for preparing clopidogrel
Inventor: PANDEY BIPIN
IPC: A61K31/4365
Filed: 2002-01-21
Abstract: The present invention discloses a process for the preparation of thieno[3,2-c]pyridine derivatives of general formula (I), in either racemic or optically active (+) or (-) forms and their salts, wherein X, the substituent on benzene ring represents either a hydrogen or halogen atom such as fluorine, chlorine, bromine or iodine. The present invention also describes a process for preparing the compounds of general formula (II), in either racemic or optically active (+) or (-) forms and their salts, where X, the substituent on benzene ring represents either a hydrogen or halogen atom such as fluorine, chlorine, bromine or iodine. The compounds represented by formulae (I) and (II) have one asymmetric carbon and hence, the optically active compounds of formula (I) or of formula (ii), may be obtained either by resolving the racemic intermediate/final product or using an optically active intermediate. The compounds of the invention are pharmacologically active and have significant anti-aggregating and anti-thrombotic properties.
Patent ES-2536573-B2 (ES)
Title: Sistema de control domótico para viviendas
Inventor: BARBOSA SIRGADO RAÚL
IPC: H04Q9/00
Filed: 2015-02-13
Granted: 2015-11-05
Abstract: Sistema (1) de control domótico para viviendas dotado de conexión a internet que comprende: un servidor (2) por cada vivienda, que controla y se comunica mediante un dispositivo transmisor de datos a través de la red eléctrica (6) con al menos un dispositivo cliente (3) situado en cada habitación de la vivienda, conectado dicho dispositivo cliente (3) al cableado de una caja de registro eléctrico de la instalación eléctrica de la vivienda y comprendiendo una pluralidad de sensores (11, 12, 13, 14, 16), una pluralidad de actuadores (15, 18, 19) y un dispositivo transmisor de datos a través de la red eléctrica (20), donde el al menos un dispositivo cliente (3) y el servidor (2) se alimentan y comunican entre sí a través del cableado de la instalación eléctrica de la vivienda, de modo que el servidor (2) manda órdenes a los dispositivos clientes (3) para controlar los dispositivos eléctricos y electrónicos instalados en dicha vivienda.
Patent ES-2641963-B2 (ES)
Title: Jarabe de sabor y olor agradables conteniendo carbohidratos, micronutrientes, y polifenoles refinados naturales de la algarroba, y método para su obtención
Inventor: MARTINEZ-FORTUN PEREZ GREGORIO
IPC: C13B20/16
Filed: 2017-08-01
Granted: 2018-06-04
Abstract: Un jarabe de sabor y olor agradable conteniendo carbohidratos, micronutrientes y polifenoles hidrosolubles refinados naturales de la vaina de algarroba y proceso para su obtención.#El jarabe comprende 20-55% sacarosa, 5-20% glucosa, 2-18% fructosa, 0.3-5% otros azúcares, 6-19% ciclitoles (principalmente D-Pinitol), 0.4-3.5% potasio, 0.35-4% compuestos fenólicos refinados y 0.3-8% impurezas orgánicas e inorgánicas.#El procedimiento engloba la extracción acuosa de los componentes hidrosolubles presentes en la vaina de la algarroba, la purificación mediante ultrafiltración por membranas, y el refinado con agentes adsorbentes, a fin de separar los componentes deseados de aquellos otros que no lo son.#El campo de aplicación del jarabe obtenido es igual al de otros azúcares y jarabes azucarados naturales.
Patent AU-2001228669-B2 (AU)
Title: Liquid air freshener or insecticidal compositions and their use
Inventor: LANG ANGUS
IPC: A61L9/04
Filed: 2001-01-26
Granted: 2005-03-03
Abstract: A non-aqueous, single phase, non-thickened liquid air freshener or insecticidal composition having a flashpoint of greater than about 62° C. is provided. The composition contains: a) a polar solvent; b) up to about 10 wt % of a non-polar aliphatic hydrocarbon solvent; and c) a fragrance or an insecticide. The composition may be dispensed from a device having a chamber with at least one wall made of a material which enables a vapor of the composition to diffuse out of the chamber.
Patent AU-2001260791-B2 (AU)
Title: Fructosyltransferases (inulosucrase and levansucrase) from lactobacillus reuteri
Inventor: RAHAOUI HAKIM
IPC: A61K35/747
Filed: 2001-05-23
Granted: 2006-11-09
Abstract: The present invention describes two novel proteins having fructosyltransferase activity. Both enzymes are derived from lactobacilli, which are food-grade microorganisms with the Generally Recognized As Safe (GRAS) status. One of these proteins produces an inulin and fructo-oligosaccharides, while the other produces a levan. According to the invention lactobacilli capable of producing an inulin and/or a levan and/or fructo-oligosaccharides using one or both of the fructosyltransferases can be used as a probiotic or a symbiotic.
Patent AU-2001277654-B2 (AU)
Title: Hypoxic fire prevention and fire suppression systems and breathable fire extinguishing compositions
Inventor: KOTLIAR IGOR K
IPC: A62D1/00
Filed: 2001-04-05
Granted: 2006-09-07
Abstract: Fire prevention and suppression systems and breathable fire-extinguishing compositions are provided for rooms, houses and buildings, transportation tunnels and vehicles, underground and underwater facilities, marine vessels, submarines, passenger and military aircraft, space stations and vehicles, military installations and vehicles, and all other human occupied objects and facilities. The system provides a breathable hypoxic fire-preventative atmosphere at standard atmospheric or local ambient pressure. The system employs an oxygen-extraction apparatus supplying oxygen-depleted air inside a human-occupied area or storing it in a high-pressure container for use in case of fire. A breathable fire-extinguishing composition is introduced for constant fire-preventive environments, being mostly a mixture of nitrogen and oxygen and having oxygen content ranging from 12% to 17%. A fire-suppression system is provided employing a fire-extinguishing composition with oxygen concentration under 16%, so when released it creates a breathable fire-suppressive atmosphere having oxygen concentration of approximately 16% (or lower if needed) with possible addition of carbon dioxide. A technology for automatically maintaining a breathable fire-preventive composition on board a human-occupied hermetic object is provided by introducing inert ballast that automatically maintains oxygen content under the Hypoxic Threshold. An aircraft fire prevention and suppression systems are provided utilizing hypoxic fire extinguishing compositions for producing breathable atmosphere onboard having fire-retarding properties.
Patent AU-2003201649-B2 (AU)
Title: Inducible transposition in transgenic organism using transposon vector
Inventor: SAVAKIS CHARALAMBOS
IPC: A01K67/00
Filed: 2003-01-09
Granted: 2008-01-24
Abstract: A method of inducing transposition in a transgenic embryo is described, comprising the steps of: (a) generating a first adult transgenic organism comprising within its genome one or more copies of a transposon; (b) generating a second adult transgenic organism comprising within its genome one or more copies of a gene encoding a transposase cognate for said transposon and/or a sequence capable of regulating expression of said gene encoding the transposase; (c) crossing the first adult transgenic organism with the second transgenic adult organism to provide a progeny which comprises, in the genome of one or more of its cells, both (i) one or more copies of the transposon and (ii) a gene encoding a transposase cognate for said transposon, wherein the gene encoding the transposase is under the control of one or more inducible regulatory sequences which permit expression of the transposase, and (d) inducing expression of said gene encoding-the transposase in said embryo to cause mobilisation of said transposon within at least a portion of the tissues or cells of the progeny. Using the method, mobilisation of a transposon can advantageously be induced at predetermined stages of development of an embryo and the mutated gene of a single cell may be replicated in subsequent cell divisions, resulting in groups of cells which are essentially homogeneous for the transposed gene.
Patent AU-2003300266-B2 (AU)
Title: Methods and compositions for suppressing fibrocyte differentiation
Inventor: PILLING DARRELL
IPC: A61K39/395
Filed: 2003-12-22
Granted: 2009-10-08
Abstract: A wound dressing for treating a wound, comprising an amount of a composition that binds SAP and locally depletes or suppresses SAP sufficient to increase monocyte differentiation into fibrocytes and promote healing of the wound.
Patent AU-2004235607-B2 (AU)
Title: Rotary joint of articulation prosthetic implement having rotating load setting means, articulation prosthetic implement using the rotary joint and method of making articulation prosthetic implement
Inventor: DAIJU SATORU
IPC: A61F5/01
Filed: 2004-12-01
Granted: 2009-12-24
Abstract: The present invention comprises outer member (7) with flanges (7A) at either end, having inner rotary shaft (7C) and annular depression (7B) around the rotary shaft, one-way clutch (50) for externally engaging the rotary shaft (7C), metal bush (52) for externally engaging the one-way clutch, synthetic resin bush (54) for externally engaging the metal bush (52), brake bush (56) for externally engaging the synthetic resin bush, cylindrical projection (58) which is fitted in annular depression (7B) of the outer member located outside the brake bush, inner member (6) with flanges at either end, and a stopper mechanism for controlling the range of rotary shaft rotation which is installed at inner projection (7D) of rotary shaft (7C). Such a construction enables the execution of torque tests with a single unit of an articulation prosthetic implement rotary joint having a rotating load setting means. <IMAGE> <IMAGE>
Patent AU-2005231362-B2 (AU)
Title: Head-to-head connector spinal fixation system
Inventor: DOHERTY THOMAS
IPC: A61B17/80
Filed: 2005-03-29
Granted: 2010-05-13
Abstract: A spinal fixation system comprising at least two bone anchors, a rod connecting the bone anchors and a connecting plate extending from a proximal surface of at least one of the bone anchors. A method of fixing vertebrae relative to each other comprising the steps of: implanting bone anchors in two adjacent vertebrae, each bone anchor having a rod receiving portion; placing a rod in the rod receiving portions, thereby connecting the bone anchors; threadably engaging set screws in the rod receiving portions of at least a portion of the bone anchors, thereby fixing the rod to the bone anchors; mating one end of a connecting plate to a proximal bearing surface of at least a portion of the bone anchors; and engaging a cap with at least a portion of the set screws, thereby fixing the connecting plate to the bone anchors.
Patent AU-2005238459-B2 (AU)
Title: Process to upgrade hydrocarbonaceous feedstreams
Inventor: SOLED STUART LEON
IPC: C10G47/00
Filed: 2005-04-19
Granted: 2010-04-15
Abstract: The instant invention relates to a process to produce liquid products through the hydroprocessing of hydrocarbonaceous feedstreams in the presence of a bulk metal hydroprocessing catalyst.
Patent AU-2005316828-B2 (AU)
Title: Method for estimating confined compressive strength for rock formations utilizing Skempton theory
Inventor: MALCOLM CALHOUN WILLIAM
IPC: G06F17/10
Filed: 2005-12-09
Granted: 2011-07-21
Abstract: A method for estimating the CCS for a rock in the depth of cut zone of a subterranean formation which is to be drilled using a drilling fluid is disclosed. An UCS is determined for a rock in the depth of cut zone. A change in the strength of the rock due to applied stresses imposed on the rock during drilling id calculated which includes estimating the ΔPP. The CCS for the rock in the depth of cut zone is calculated by adding the estimated change in strength to the UCS. The present invention calculates the ΔPP in accordance with Skempton theory where impermeable rock or soil has a change in pore volume due to applied loads or stresses while fluid flow into and out of the rock or soil is substantially non-existent. CCS may be calculated for deviated wellbores and to account for factors such as wellbore profile, stress raisers, bore diameter, and mud weight utilizing correction factors derived using computer modeling and using a baseline formula for determining an uncorrected value for CCS.
Patent AU-2006203792-B2 (AU)
Title: Glycopegylated Granulocyte Colony Stimulating Factor
Inventor: ZOPF DAVID A
IPC: C12P21/02
Filed: 2006-01-10
Granted: 2011-11-03
Abstract: The present invention provides conjugates between Granulocyte Colony Stimulating Factor and PEG moieties. The conjugates are linked via an intact glycosyl linking group that is interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from both glycosylated and unglycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto either an amino acid or glycosyl residue on the peptide. Also provided are pharmaceutical formulations including the conjugates. Methods for preparing the conjugates are also within the scope of the invention.
Patent AU-2006214534-B2 (AU)
Title: Polypeptides from Staphylococcus aureus and methods of use
Inventor: EMERY DARYLL A
IPC: G01N33/569
Filed: 2006-02-14
Granted: 2012-07-19
Abstract: The present invention provides isolated polypeptides isolatable from a spp. Also provided by the present invention are compositions that include one or more of the polypeptides, and methods for making and methods for using the polypeptides.
Patent AU-2006262603-B2 (AU)
Title: Compositions and methods for the diagnosis and treatment of tumor
Inventor: MALLET WILLIAM
IPC: A61K39/00
Filed: 2006-06-14
Granted: 2011-01-06
Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
Patent AU-2006284622-B2 (AU)
Title: Des-C,D analogs of 1alpha,25-dihydroxy-19-norvitamin D3
Inventor: KATARZYNA PLONSKA-OCYPA
IPC: A61K31/045
Filed: 2006-08-30
Granted: 2011-10-06
Abstract: -C,D 2-methylene-19-norvitamin D analogs are provided including compounds of formula 1, in which R is a straight or branched chain alkyl or alkylene group having from 8 to 27 carbons and bearing an OY group; and Y, Y and Y are independently selected from H or hydroxy-protecting groups. Such compounds may be used in preparing pharmaceutical compositions and are useful in treating a variety of biological conditions. Formula(I)